Sunday, December 07, 2025 | 08:31 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Pfizer vaccine's -70 degree storage norm tough for most nations: V K Paul

Limited number of doses would not be enough to meet India's demand, adds Niti Aayog member

Pfizer
premium

US drug-maker Pfizer has reported that its vaccine BNT162b2, has been more than 90 per cent effective in late-stage trials.

Ruchika Chitravanshi New Delhi
As the national committee on covid vaccine firms up the national scheme for vaccine distribution and evaluates the available vaccine options, the government feels that not only do the cold chain requirements for Pfizer’s candidate pose a major challenge, its limited number of doses would not be enough to meet India’s demand. 

“In our knowledge there is only one vaccine that needs to be kept in -70 to -80 degree Celsius temperature which will be difficult for all countries which make it difficult to scale up...We are discussing this as the Pfizer’s vaccine will not be available to us for